Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Marcel

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Circulation|May 26, 2004
Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early dischargeGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Thrombosis and Haemostasis|June 4, 2004
Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stentingGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Circulation|February 26, 2004
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failureGiuseppe De Luca, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
Journal of the American College of Cardiology|April 6, 2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 8, 2005
Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
The Journal of Invasive Cardiology|March 6, 2012
Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding scoreRenicus S Hermanides, Jan Paul Ottervanger, Jurrien M ten Berg, et al.
European Heart Journal|August 12, 2003
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromesArnoud W J van 't Hof, Suzanna T de Vries, Jan-Henk E Dambrink, et al.
Thrombosis and Haemostasis|August 12, 2011
Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarctionRenicus S Hermanides, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
American Heart Journal|December 13, 2005
Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
American Heart Journal|December 13, 2005
Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarctionGiuseppe De Luca, Arthur C Maas, Harry Suryapranata, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Circulation|May 26, 2004
Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early dischargeGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Thrombosis and Haemostasis|June 4, 2004
Comparison between ticlopidine and clopidogrel in patients with ST-segment elevation myocardial infarction treated with coronary stentingGiuseppe De Luca, Harry Suryapranata, Arnoud W J van 't Hof, et al.
Circulation|February 26, 2004
Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failureGiuseppe De Luca, Arnoud W J van 't Hof, Menko-Jan de Boer, et al.
Journal of the American College of Cardiology|April 6, 2005
Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarctionJorik R Timmer, Jan Paul Ottervanger, Menko-Jan de Boer, et al.
American Heart Journal|October 8, 2005
Preprocedural Thrombolysis in Myocardial Infarction (TIMI) flow significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute anterior myocardial infarction treated by primary angioplastyGiuseppe De Luca, Nicolette Ernst, Arnoud W J van 't Hof, et al.
The Journal of Invasive Cardiology|March 6, 2012
Net clinical benefit of prehospital glycoprotein IIb/IIIa inhibitors in patients with ST-elevation myocardial infarction and high risk of bleeding: effect of tirofiban in patients at high risk of bleeding using CRUSADE bleeding scoreRenicus S Hermanides, Jan Paul Ottervanger, Jurrien M ten Berg, et al.
European Heart Journal|August 12, 2003
A comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b/3a upstream therapy and acute coronary syndromesArnoud W J van 't Hof, Suzanna T de Vries, Jan-Henk E Dambrink, et al.
Thrombosis and Haemostasis|August 12, 2011
Suboptimal anticoagulation with pre-hospital heparin in ST-elevation myocardial infarctionRenicus S Hermanides, Jan Paul Ottervanger, Jan-Henk E Dambrink, et al.
American Heart Journal|December 13, 2005
Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplastyGiuseppe De Luca, Harry Suryapranata, Jan Paul Ottervanger, et al.
American Heart Journal|December 13, 2005
Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarctionGiuseppe De Luca, Arthur C Maas, Harry Suryapranata, et al.
Pageof 9